Omnipaque Injection 350 Mg

About Omnipaque Injection 350 Mg

Omnipaque 350 mg/mL Injection is a contrast medium used in radiological imaging procedures. It contains iohexol as the active ingredient, a non-ionic, water-soluble contrast agent that helps improve the visibility of blood vessels, organs, and other internal structures during diagnostic imaging like X-rays, CT scans, and angiography.

Key Details about Omnipaque 350 mg/mL Injection:

Active Ingredient:

• Iohexol (350 mg per mL) - A contrast agent used to enhance the visibility of internal structures during imaging procedures.

Common Uses:

• Computed Tomography (CT) Scans: Omnipaque 350 is commonly used in CT imaging, particularly for angiography, myelography, and head, neck, chest, abdominal, and pelvic scans. It helps to outline blood vessels, tumors, or other anatomical structures by providing clearer images.
• Angiography: It is used during angiography to visualize blood vessels and detect blockages or abnormalities in the cardiovascular system.
• Intravascular Imaging: Omnipaque is often used for intravascular procedures such as catheter placement, where clear imaging of blood vessels is required.
• Myelography: It is also used in myelography, where the contrast medium is injected into the spinal canal to enhance imaging of the spinal cord, nerves, and surrounding areas.

Mechanism of Action:

• Contrast Enhancement: Iohexol is an iodine-based contrast medium. When injected into the body, it absorbs X-rays and appears white or bright on imaging scans. This contrast allows for better visualization of soft tissues, blood vessels, organs, and other structures.
• Non-Ionic Contrast Agent: As a non-ionic agent, Omnipaque is designed to reduce the risk of adverse reactions compared to older ionic contrast agents, making it safer for many patients.

Administration:

• Route: Omnipaque is administered through different routes depending on the procedure:
  • Intravenous (IV): For CT scans or imaging of blood vessels and organs.
  • Intra-arterial: For procedures like angiography.
  • Intrathecal: For imaging the spinal cord (myelography).
• Dosage: The dosage varies depending on the procedure and patient characteristics. The physician will decide the appropriate dose based on factors such as the type of imaging, the patient's medical condition, and their weight.

Side Effects:

• Common Side Effects:
  • Mild reactions at the injection site, such as pain, redness, or swelling.
  • Nausea or vomiting.
  • Headache.
  • A sensation of warmth or flushing after injection.
• Serious Side Effects:
  • Allergic reactions (e.g., rash, itching, swelling, difficulty breathing) can occur in rare cases, especially in patients who have a history of sensitivity to contrast agents or iodine.
  • Kidney problems: Omnipaque can cause kidney function impairment, particularly in patients with pre-existing kidney disease or in those who are dehydrated.
  • Severe reactions: Rarely, patients may experience severe reactions such as hypotension (low blood pressure), cardiac arrhythmias, or severe allergic reactions like anaphylaxis.

Precautions:

• Kidney Function: Omnipaque should be used with caution in patients with pre-existing kidney conditions (e.g., renal insufficiency, diabetes) because of the potential for contrast-induced nephropathy (kidney damage).
• Hydration: Patients should be well-hydrated before receiving Omnipaque, especially if they have kidney concerns. Hydration helps to minimize the risk of kidney-related complications.
• Pregnancy and Breastfeeding: Omnipaque should only be used during pregnancy if the benefits outweigh the risks. It is advised to consult with a healthcare provider about the safety of using contrast agents while breastfeeding.
• Allergies to Iodine: If a patient has a known allergy to iodine-based contrast agents, Omnipaque may be contraindicated. The healthcare provider may use a different imaging method or contrast agent.
• Thyroid Function: In rare cases, exposure to iodine-based contrast agents can affect thyroid function, especially in patients with pre-existing thyroid disorders.

Interactions:

• Medications: Certain medications can interact with Omnipaque, especially those that affect kidney function, such as NSAIDs, diuretics, and ACE inhibitors.
• Antidiabetic drugs: Patients taking metformin (for diabetes) should temporarily discontinue it before receiving contrast media like Omnipaque, due to the potential for lactic acidosis in patients with kidney problems.

Storage:

• Store Omnipaque at room temperature (between 15C to 30C or 59F to 86F).
• Keep the vial tightly sealed and protected from light. Do not freeze the medication.
• Check the expiration date on the vial before use, and do not use the product if it is past the expiration date or if the vial has been damaged.

Contraindications:

• Hypersensitivity: Omnipaque is contraindicated in patients with known hypersensitivity to iohexol or any other component of the formulation.
• Severe Renal Impairment: In patients with severe kidney problems, Omnipaque may not be recommended due to the risk of kidney complications.

Conclusion:

Omnipaque 350 mg/mL Injection is a highly effective and commonly used contrast medium for imaging procedures such as CT scans, angiography, and myelography. It helps improve the clarity of X-ray and CT images by enhancing the contrast of internal organs and structures. As with any contrast agent, it is important to carefully consider the patient's medical history and renal function to minimize the risk of side effects.

Advanced Imaging Clarity for Accurate Diagnosis

Omnipaque Injection 350 mg enhances visibility of blood vessels, organs, and tissues in X-ray and CT scan images due to its high concentration of iodine. Its non-ionic, low-osmolar formulation ensures excellent image contrast and diagnostic accuracy while minimizing adverse reactions. This medical imaging solution is trusted by physicians for a broad range of diagnostic procedures requiring enhanced visualization.


Flexible Applications and Patient Safety

Intended for single-use per examination, Omnipaque Injection can be administered to both adults and children according to the physician's guidance. Its compatibility with standard IV contrast injectors provides flexibility in clinical settings. The solution is formulated to be water-soluble, sterile, minimally reactive, and well-tolerated in most patient groups, except those with hypersensitivity to iodine.


Safe Handling and Storage Guidelines

Omnipaque Injection is supplied in glass vials/bottles and should be stored at temperatures below 30C and protected from light. The product maintains stability and safety within its 36-month shelf life, provided storage instructions are followed. Always ensure single-use per exam to preserve sterility and effectiveness for optimal patient outcomes.